Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Smith & Nephew positions itself for the post-2010 generation of tissue & bone repair products

This article was originally published in Clinica

Executive Summary

Smith & Nephew's splitting of its orthopaedics division into recon and trauma in early 2006 was the latest major restructuring step for a group that has undergone much change since CEO Sir Christopher O'Donnell took charge nine years ago. In an interview with Ashley Yeo at the group's headquarters on London's Strand, he explained why this was necessary and how the group is positioning itself to be a major player in next-generation products

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT052870

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel